FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer
In Brief: Goldman Named Director, Albert Einstein Cancer Center; Wiernik Resumes Post
Fisher Files Motion In Database Flagging Suit; Documents Examine Role Of Former NCI Director Broder
Petition Filed To Revoke NlH License To Use Radioactive Materials
Extramural Advisory Board Members Listed
Komen Foundation Awards New Grants
Trending Stories
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations
BIO calls for the end of “constant turmoil,” urges the administration to “right the ship” - Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report
- Anthony Letai pledges to ensure stability for extramural and intramural cancer science
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program









